Cargando…

Combinatorial therapy with an IL-15 superagonist (ALT-803) and anti-PD-L1 mAb augment T cell mediated anti-tumor immunity in mice

Detalles Bibliográficos
Autores principales: Johnson, Christopher B, Riesenberg, Brian, Neitzke, Dan, Jeng, Emily K, Marcus, Warren D, Cole, David, Wong, Hing C, Rubinstein, Mark P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292513/
http://dx.doi.org/10.1186/2051-1426-2-S3-P234
_version_ 1782352491836342272
author Johnson, Christopher B
Riesenberg, Brian
Neitzke, Dan
Jeng, Emily K
Marcus, Warren D
Cole, David
Wong, Hing C
Rubinstein, Mark P
author_facet Johnson, Christopher B
Riesenberg, Brian
Neitzke, Dan
Jeng, Emily K
Marcus, Warren D
Cole, David
Wong, Hing C
Rubinstein, Mark P
author_sort Johnson, Christopher B
collection PubMed
description
format Online
Article
Text
id pubmed-4292513
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42925132015-01-15 Combinatorial therapy with an IL-15 superagonist (ALT-803) and anti-PD-L1 mAb augment T cell mediated anti-tumor immunity in mice Johnson, Christopher B Riesenberg, Brian Neitzke, Dan Jeng, Emily K Marcus, Warren D Cole, David Wong, Hing C Rubinstein, Mark P J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4292513/ http://dx.doi.org/10.1186/2051-1426-2-S3-P234 Text en Copyright © 2014 Johnson et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Johnson, Christopher B
Riesenberg, Brian
Neitzke, Dan
Jeng, Emily K
Marcus, Warren D
Cole, David
Wong, Hing C
Rubinstein, Mark P
Combinatorial therapy with an IL-15 superagonist (ALT-803) and anti-PD-L1 mAb augment T cell mediated anti-tumor immunity in mice
title Combinatorial therapy with an IL-15 superagonist (ALT-803) and anti-PD-L1 mAb augment T cell mediated anti-tumor immunity in mice
title_full Combinatorial therapy with an IL-15 superagonist (ALT-803) and anti-PD-L1 mAb augment T cell mediated anti-tumor immunity in mice
title_fullStr Combinatorial therapy with an IL-15 superagonist (ALT-803) and anti-PD-L1 mAb augment T cell mediated anti-tumor immunity in mice
title_full_unstemmed Combinatorial therapy with an IL-15 superagonist (ALT-803) and anti-PD-L1 mAb augment T cell mediated anti-tumor immunity in mice
title_short Combinatorial therapy with an IL-15 superagonist (ALT-803) and anti-PD-L1 mAb augment T cell mediated anti-tumor immunity in mice
title_sort combinatorial therapy with an il-15 superagonist (alt-803) and anti-pd-l1 mab augment t cell mediated anti-tumor immunity in mice
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292513/
http://dx.doi.org/10.1186/2051-1426-2-S3-P234
work_keys_str_mv AT johnsonchristopherb combinatorialtherapywithanil15superagonistalt803andantipdl1mabaugmenttcellmediatedantitumorimmunityinmice
AT riesenbergbrian combinatorialtherapywithanil15superagonistalt803andantipdl1mabaugmenttcellmediatedantitumorimmunityinmice
AT neitzkedan combinatorialtherapywithanil15superagonistalt803andantipdl1mabaugmenttcellmediatedantitumorimmunityinmice
AT jengemilyk combinatorialtherapywithanil15superagonistalt803andantipdl1mabaugmenttcellmediatedantitumorimmunityinmice
AT marcuswarrend combinatorialtherapywithanil15superagonistalt803andantipdl1mabaugmenttcellmediatedantitumorimmunityinmice
AT coledavid combinatorialtherapywithanil15superagonistalt803andantipdl1mabaugmenttcellmediatedantitumorimmunityinmice
AT wonghingc combinatorialtherapywithanil15superagonistalt803andantipdl1mabaugmenttcellmediatedantitumorimmunityinmice
AT rubinsteinmarkp combinatorialtherapywithanil15superagonistalt803andantipdl1mabaugmenttcellmediatedantitumorimmunityinmice